Efficacy and safety of aminoglycoside monotherapy: Systematic review and meta-analysis of randomized controlled trials

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 2, 2007, Pages 247-257

  Vidal, Liat ^a   Gafter Gvili, Anat ^a,b   Borok, Sara ^a   Fraser, Abigail ^c   Leibovici, Leonard ^a,b   Paul, Mical ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Antibiotics; Infections; Meta analysis; Sepsis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; AZLOCILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBENICILLIN; CARUMONAM; CEFALORIDINE; CEFOPERAZONE; CEFSULODIN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; FOSFOMYCIN; GENTAMICIN; JOSAMYCIN; KANAMYCIN; LATAMOXEF; NALIDIXIC ACID; NETILMICIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; TOBRAMYCIN;

ABDOMINAL INFECTION; CLINICAL PROTOCOL; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EMBASE; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER DISEASE; MEDLINE; META ANALYSIS; MONOTHERAPY; MORTALITY; NEPHROTOXICITY; PHLEBITIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; REVIEW; SENSITIVITY ANALYSIS; SEPSIS; SKIN DISEASE; SOFT TISSUE INFECTION; SYSTEMATIC REVIEW; URINARY TRACT INFECTION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE, BACTERIAL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 34547841563     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm193     Document Type: Review

References (110)

1. Vander Stichele RH, Elseviers MM, Ferech M et al. Hospital consumption of antibiotics in 15 European countries: Results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 2006; 58: 159-67.
2. Brummett RE, Fox KE. Aminoglycoside-induced hearing loss in humans. Antimicrob Agents Chemother 1989; 33: 797-800.
3. Pittinger CB. Convergence of interests in antibiotic-induced neuromuscular blockade. Acta Physiol Pharmacol Latinoam 1989; 39: 393-6.
4. Swan SK. Aminoglycoside nephrotoxicity. Semin Nephrol 1997; 17 27-33.
5. Siegman-Igra Y, Ravona R, Primerman H et al. Pseudomonas aeruginosa bacteremia: An analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis 1998; 2: 211-5.
6. Crabtree TD, Pelletier SJ, Gleason TG et al. Analysis of aminoglycosides in the treatment of gram-negative infections in surgical patients. Arch Surg 1999; 134: 1293-8; discussion 8-9.
7. Leibovici L,, Paul M, Poznanski O et al. Monotherapy versus β-lactam-aminoglycoside combination treatment for gram-negative bacteremia: A prospective, observational study. Antimicrob Agents Chemother 1997; 41: 1127-33.
8. Paul M, Benuri-Silbiger I, Soares-Weiser K et al. β-Lactam monotherapy versus β-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: Systematic review and meta-analysis of randomised trials. BMJ 2004; 328: 668.
9. Paul M, Soares-Weiser K, Leibovici L. β-Lactam monotherapy versus β-lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ 2003; 326: 1111.
10. Pfaller MA, Jones RN, Doern GV et al. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42: 1762-70.
11. Jones RN, Sader HS, Beach ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). Int J Antimicrob Agents 2003; 22: 551-6.
12. Standing Medical Advisory Committee (SMAC) SubGroup on Antimicrobial Resistance. The Path of Least Resistance. http://www.advisorybodies.doh.gov.uk/smac1.htm (1 October 2006 date last accessed).
13. Ibrahim EH, Sherman G, Ward S et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146-55.
14. Leone M, Bourgoin A, Cambon S et al. Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome. Crit Care Med 2003; 31: 462-7.
15. Fraser A, Paul M, Almanasreh N et al. Benefit of appropriate empirical antibiotic treatment: Thirty-day mortality and duration of hospital stay. Am J Med 2006; 119: 970-6.
16. Leibovici L, Shraga I, Drucker M et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379-86.
17. Mandell G, Bennett J, Dolin R. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. St. Louis: Elsevier Churchill Livingstone, 2005.
18. Wenzel RP. The antibiotic pipeline - challenges, costs, and values. N Engl J Med 2004; 351: 523-6.
19. Pitlik S. Old drugs for new bugs. BMJ 2003; 326: 235-6.
20. Higgins JPT, Green S, ads. Cochrane Handbook for Systematic Review of Interventions 426 [updated September 2006] The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd, 2006.
21. Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol 2002; 31: 150-3.
22. Schulz KF, Chalmers I, Hayes RJ et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12.
23. Albertazzi A, Bonadio M, Fusaroli M et al. Comparative multi-center study between aztreonam and gentamycin in the treatment of renal and urinary infections. G Ital Chemioter 1985; 32: 465-8.
24. Bonadio M, Maccanti O, Pulitano L et al. Comparative study of the effectiveness and renal tolerance of aztreonam (1 daily dosage) and gentamycin (2 daily doses) in the therapy of renal and urinary infections. G Ital Chemioter 1985; 32: 459-63.
25. Borowka A, Meszaros J, Krzeski T et al. Effectiveness of netilmicin in the treatment of urinary tract infections. Pol Tyg Lek 1983; 38: 1285-7.
26. Cohn I, Jr. Intestinal antisepsis. Surg Gynecol Obstet 1970; 130: 1006-14.
27. Demos CH, Green E. Review of clinical experience with amdinocillin monotherapy and comparative studies. Am J Med 1983; 75: 72-81.
28. Giamarellou H, Poulopoulos B, Katsabas A et al. Antibacterial activity of Ro 13-9904 and preliminary experience in gonorrhoea and chronic urinary tract infections. Chemotherapy 1981; 27 Suppl 1: 70-4.
29. Giuliani G, Menduni T, Fulgido G et al. Infections of the inferior urinary ways in geriatric patients at risk for bedsores. Note II - Evaluation of cinoxacine and ciprofloxacine. Gazzetta Medica Italiana Archivio per le Scienze Mediche 1994; 153: 197-205.
30. Gorbach SL, McGowan K. Comparative clinical trials in treatment of intra-abdominal sepsis. J Antimicrob Chemother 1981; 8 Suppl D: 95-104.
31. Keighley MR, Drysdale RB, Quoraishi AH et al. Antibiotic treatment of biliary sepsis. Surg Clin North Am 1975; 55: 1379-90.
32. Olbing H, Neussell H, Senge T et al. Problems in the therapy of Pseudomonas infections of the urinary tract. Alternating comparison of carbenicillin and gentamycin in children. Dtsch Med Wochenschr 1971; 96: 183-9.
33. Rajan VS, Sng EH, Thirumoorthy T et al. Ceftriaxone in the treatment of ordinary penicillinase-producing strains of Neisseria gonorrhoeae. Br J Vener Dis 1982; 58: 314-6.
34. Gallego J, Jimenez Cruz JF, Gobernado M et al. Aztreonam versus tobramycin in acute pyelonephritis. A comparative study. Arch Esp Urol 1989; 42: 116-9.
35. Stiver HG, Goldring AM, Snelling CF et al. Ceftazidime therapy versus aminoglycoside therapy in patents with gram-negative bum wound infections. J Bum Care Rehabil 1987; 8: 19-22.
36. Swabb EA, Cone CO, Muir JG. Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infections. Rev Infect Dis 1985; 7 Suppl 4: S675-8.
37. Swabb EA, Jenkins SA, Muir JG. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections. Rev Infect Dis 1985; 7 Suppl 4: S772-7.
38. del Rosal PL. A comparative study of the efficacy and safety of azlocillin and gentamicin in the treatment of serious infections. J Antimicrob Chemother 1983; 11 Suppl B: 159-67.
39. DeMaria A, Jr, Treadwell TL, Saunders CA et al. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli. Antimicrob Agents Chemother 1989; 33: 1137-43.
40. Cherubin C, Stilwell S. Norfloxacin versus parenteral therapy in the treatment of complicated urinary tract infections and resistant organisms. Scand J Infect Dis Suppl 1986; 48: 32-7.
41. Gudiol F, Pallares R, Ariza X et al. Comparative clinical evaluation of aztreonam versus aminoglycosides in gram-negative septicaemia. J Antimicrob Chemother 1986; 17: 661-71.
42. Heimbach DM. Cefsulodin therapy for infections due to Pseudomonas aeruginosa in patients with burns. Rev Infect Dis 1984; 6 Suppl 3: S744-50.
43. Henry SA. Overall clinical experience with aztreonam in the treatment of intraabdominal infections. Rev Infect Dis 1985; 7 Suppl 4: S729-33.
44. Moore RD, Smith CR, Holloway JJ et al. Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness. Arch Intern Med 1986; 146: 1153-7.
45. Nolen TM, Phillips HL, Hall HJ. Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli. Rev Infect Dis 1985; 7 Suppl 4: S666-8.
46. Sabbaj J, Torres M, Loza L. Comparative clinical evaluation of azlocillin and gentamicin. J Antimicrob Chemother 1983; 11 Suppl B: 175-81.
47. Schentag JJ, Vari AJ, Winslade NE et al. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia. Am J Med 1985; 78: 34-41.
48. Wing DA, Hendershott CM, Debuque L et al. A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy. Obstet Gynecol 1998; 92: 249-53.
49. Sage R, Nazareth B, Noone P. A prospective randomised comparison of cefolaxime vs. netilmicin vs. cefotaxime plus netilmicin in the treatment of hospitalised patients with serious sepsis. Scand J Infect Dis 1987; 19: 331-7.
50. Rodriguez JR, Ramirez-Ronda CH. Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections. Am J Med 1985; 78: 42-3.
51. Rodriguez JR, Ramirez-Ronda CH, Nevarez M. Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli. Antimicrob Agents Chemother 1985; 27: 246-51.
52. Cheng IK, Chan CY, Wong WT. A randomised prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1991; 11: 27-30.
53. Greenberg RN, Reilly PM, Luppen KL et al. Treatment of serious gram-negative infections with aztreonam. J Infect Dis 1984; 150 623-30.
54. Hyatt AC, Chipps BE, Kumor KM et al. A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis. J Pediatr 1981; 99: 307-14.
55. Nishiura T. Clinical compadson of cefoperazone in complicated urinary tract infections using a double-blind method. Clin Ther 1980; 3 190-205.
56. Gwon A. Ofloxacin vs tobramycin for the treatment of external ocular infection. Ofloxacin Study Group II. Arch Ophthalmol 1992; 110 1234-7.
57. Proctor DS. The treatment of burns: A comparative trial of antibiotic dressings. S Afr Med J 1971; 45: 231-6.
58. Gillen P, Ryan W, Peel AL. A prospective randomised controlled trial of mezlocillin versus netilmicin in biliary surgery. Ann R Coll Surg Engl 1985; 67: 376-8.
59. Marti MC, Auckenthaler R. Antibiotic prophylaxis in colorectal surgery: results of a randomized clinical study. Helv Chir Acta 1982; 49 527-36.
60. Marti MC, Auckenthaler R. Antibiotic prophylaxis in large bowel surgery: results of a controlled clinical trial. Surgery 1983; 93: 190-6.
61. Hara K, Saito A, Yamaguchi K et al. Comparative clinical trial of HBK amikacin (AMK) in the treatment of respiratory infections. Kansenshogaku Zasshi 1987; 61: 22-53.
62. Howard JE, Donoso E, Mimica I et al. Gentamicin for urinary-tract infections in infants. J Infect Dis 1971; 124 Suppl: S234-5.
63. Kumazawa J, Momose S. Clinical effectiveness of lividomycin on urinary tract infections: Evaluation with double-blind method. Curr Ther Res Clin Exp 1973; 15: 873-901.
64. LeFrock JL, Carr BB, Blias F et al. A comparative study of gentamicin and netilmicin in the treatment of gram-negative infections. Drug Intell Clin Pharm, 1985; 19: 309-15.
65. Madsen PO, Kjaer TB, Mosegaard A. Comparison of tobramycin and gentamicin in the treatment of complicated urinary tract infections. J Infect Dis 1976; 134 Suppl: S150-2.
66. Madsen PO, Kjaer TB, Mosegaard A. Treatment of complicated urinary tract infections. Comparative study of sisomicin and gentamicin. Urology 1977; 9: 635-8.
67. Paoletti V, Mammarella A, Mariani A et al. Netilmicin in the treatment of infections of the lower urinary tract. Clin Ter 1989; 128: 406-9.
68. Shishito S. Clinical evaluation of the therapeutic affect of vistamycin and kanamycin on the various urinary tract infections - analysis by double blind method. Hinyokika Kiyo 1972; 18: 160-72.
69. Echols RM, Heyd A, O'Keeffe BJ et al. Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: A worldwide summary. Sex Transm Dis 1994; 21: 345-52.
70. Cecconi M, Manfredi R, Cecarini L et al. Early indicators of nephrotoxicity: Comparison of two antibiotics. Int J Clin Pharmacol Ther Toxicol 1987; 25: 452-7.
71. Abbruzzese JL, Rocco LE, Laskin OL et al. Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections. Am J Med 1983; 74: 694-9.
72. Albertazzi A, Bonadio M, Fusaroli M et al. Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections. Chemotherapy 1989; 35 Suppl 1: 77-80.
73. Bailey RR, Lynn KL, Peddie BA et al. Comparison of netilmicin with ceftriaxone for the treatment of severe or complicated urinary tract infections. N Z Med J 1986; 99: 459-61.
74. Bailey RR, Lynn KL, Robson RA et al. Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis. N Z Med J 1992; 105: 102-3.
75. Bailey RR, Peddie BA, Lynn KL et al. Comparison of natilmicin with cefoperazone for the treatment of severe or complicated urinary tract infections. Aust N Z J Med 1985; 15: 22-6.
76. Bernstein Hahn L, Barclay CA, Iribarren MA et al. Ceftriaxone, a new parenterall caphalosporin, in the treatment of urinary tract infections. Chemotherapy 1981; 27 Suppl 1: 75-9.
77. Chen TA, Lo GH, Lai KH et al. Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics. World J Gastroentetol 2005; 11: 6823-7.
78. Cox CE. A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections. J Antimicrob Chemother 1983; 12 Suppl A: 47-52.
79. Elder HA, Roy I. Treatment of urinary tract infections due to Pseudomonas aeruginosa with cefsulodin. Rev Infect Dis 1984; 6 Suppl 3: S734-43.
80. Fang GD, Brennen C, Wagener M et al. Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: Prospective, randomized clinical and pharmacokinetic study. Antimicrob Agents Chemother 1991; 35: 1849-55.
81. Frimodt-Moller PC, Madsen PO. Ceftazidime, a now cephalosporin in the treatment of complicated urinary tract infections: A comparative study with tobramycin. J Urol 1983; 130: 796-7.
82. Gonzalez MA. A comparison of azlocillin and gentamicin in the treatment of serious infections caused by Pseudomonas aeruginosa. J Antimicrob Chemother 1983; 11 Suppl B: 169-74.
83. Gorski J, Wehnert J, Lange D et al. A clinical trial of pefloxacin (Abaktal) in the treatment of acute pyelonephritis. Z Urol Nephrol 1990; 83: 55-60.
84. Hahn LB, Iribarren M, Barclay C et al. Comparative study of Ro 17-2301 (AMA-1080) and amikacin in complicated urinary tract infections. Chemioterapia 1987; 6: 519-21.
85. Hoepelman AI, Bakker LJ, Verhoef J. Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections. Antimicrob Agents Chemother 1988; 32: 473-6.
86. Islam MR, Alam AN, Hossein MS et al. Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children. J Trop Pediatr 1994; 40: 320-5.
87. Klastersky J, Cappel R, Daneau D. Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods. Cancer 1973; 31: 331-6.
88. Kleinschmidt K, Weissbach L, Bode HU et al. One-time therapy of acute cystitis in women Comparison between gentamycin and amoxicillin. Dtsch Med Wochenschr 1983; 108: 1837-40.
89. Laga M, Naamara W, Brunham RC et al. Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone. N Engl J Med 1986; 315: 1382-5.
90. Lentini M, Castiello G, Scorza C et al. Comparative non-blind trial of ceftriaxone and gentamicin in the treatment of complicated urinary tract infections. J Int Med Res 1982; 10: 166-78.
91. Lepage JY, Juge C, Cozian A et al. Comparative study of first-line ceftriaxone and amikacin in the treatment of severe urinary tract infections in the adult. Pathol Biol (Paris) 1987; 35: 638-41.
92. Ludwig G, Knebel L. Cefotaxime in urinary tract infections- comparative clinical studies with gentamicin and with cefoxitin. J Antimicrob Chemother 1980; 6 Suppl A: 207-11.
93. Madsen PO, Frimodt-Moller PC. Complicated urinary tract infections treated with ceftazidime and tobramycin: A comparative study. J Antimicrob Chemother 1983; 12 Suppl A: 77-9.
94. Martin CM, Cuomo AJ, Zage JR et al. Initial, presumptive therapy for serious acute gram-negative rod infections: Preliminary report of a controlled clinical trial. Trans N Y Acad Sci 1967; 29: 589-605.
95. Melekos MD, Skoutelis A, Chryssanthopoulos C et al. A comparative study on aztreonam, ceftazidime and amikacin in the treatment of complicated urinary tract infections. J Chemother 1991; 3: 376-82.
96. Montgomerie JZ, Morrow JW, Canawati HN et al. Ceftizoxime in the treatment of urinary tract infection in spinal cord injury patients: comparison with tobramycin. J Antimicrob Chemother 1982; 10 Suppl C: 247-52.
97. Nohara N, Akagi O, Kanzaki H et al. Comparative clinical study of roxithromycin and josamycin for suppurative skin and soft tissue infections by a double-blind method. Kansenshogaku Zasshi 1989; 63: 203-27.
98. Nunziati F, Portalone L, Antilli A et al. Trial randomizzato cefoperazone versus aminoglicoside in pazienti con patologia pulmonare infettiva. Minerva Pneumologica 1985; 24: 101-2.
99. Penn RG, Preheim LC, Sanders CC et al. Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infections. Antimicrob Agents Chemother 1983; 24: 494-9.
100. Saballs P, Miralles J, Gutierrez-Cebollada J et al. Comparative study of the therapeutic efficacy of netilmicin versus ceftriaxone in single daily dosing in acute pyelonaphritis. Revista Espanola de Quimioterapia 1990; 3: 133-6.
101. Sattler FR, Moyer JE, Schramm M et al. Aztreonam compared with gentamicin for treatment of serious urinary tract infections. Lancet 1984; 1: 1315-8.
102. Seiler W, Stahelin HB, Bohni E. Clinical and bacteriological results in urinary tract infections with single-dose Ro 13-9904 (Rocephin). Chemotherapy 1981; 27 Suppl 1: 80-92.
103. Tammela T, Kontturi M, Usenius R et al. Caftazidime vs. tobramycin for serious infections in urological patients. J Hosp Infect 1990; 15 Suppl A: 69-76.
104. Varese LA. Trometamol salt of fosfomycin versus netilmicin: Randomized multicenter study in children's lower urinary tract infections. Eur Urol 1987; 13 Suppl 1: 119-21.
105. Waller DA, Kendall SW, Whelan P. A comparative trial of aztreonam versus gentamicin in the treatment of urinary tract infections. Int Urol Nephrol 1992; 24: 221-7.
106. Whang CW, Chung ES, Chang ST. Comparative study of cefoperazone and amikacin. Clin Ther 1984; 7: 40-8.
107. Zattoni F, Artibani W, Garbeglio A et al. Comparison of Rocephin and gentamicin in urinary tract infections. Abstracts of the 3rd Meditteranean Congress of Chemotherapy. Dubruvnik, 1982; Abstract 382.
108. Bailey JA, Virgo KS, DiPiro JT et al. Aminoglycosides for intra-abdominal infection: Equal to the challenge? Surg Infect (Larchmt) 2002; 3: 315-35.
109. Hilf M, Yu VL, Sharp J et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients. Am J Med 1989; 87: 540-6.
110. Korvick JA, Bryan CS, Farber B et al. Prospective observational study of klebsiella bacteremia in 230 patients: Outcome for antibiotic combinations versus monotherapy. Antimicrob. Agents Chemother 1992; 36: 2639-44.